Related Experiment Video
Updated: Jul 10, 2026

Synergetic Use of Neural Precursor Cells and Self-assembling Peptides in Experimental Cervical Spinal Cord Injury
Published on: February 23, 2015
Engineered Extracellular Vesicles Modified by Angiopep-2 Peptide Promote Targeted Repair of Spinal Cord Injury and
Guang Kong1, Jie Liu2, Juan Wang3
1Department of Orthopedics, Xijing Hospital, Fourth Military Medical University, Xi'an 710000 Shaanxi, China.
Engineered extracellular vesicles modified with Angiopep-2 peptide and melatonin effectively target spinal cord injury sites. These M-Ang2-EVs promote nerve repair, remyelination, and reduce both spinal cord and brain inflammation.
Area of Science:
- Biomedical Engineering
- Neuroscience
- Regenerative Medicine
Background:
- Engineered extracellular vesicles (EVs) are promising for spinal cord injury (SCI) treatment.
- Angiopep-2 (Ang2) targets the blood-brain barrier, and its receptor LRP-1 is upregulated post-SCI.
- Melatonin possesses anti-inflammatory properties beneficial for neuroinflammation.
Purpose of the Study:
- To develop enhanced engineered extracellular vesicles (M-Ang2-EVs) for targeting SCI.
- To investigate the therapeutic effects of M-Ang2-EVs on nerve repair and inflammation.
- To assess the dual targeting capability of M-Ang2-EVs to both spinal cord and brain.
Main Methods:
- Modification of M2 microglia with Angiopep-2 peptide and melatonin to create M-Ang2-EVs.
- Single-cell and single-nucleus sequencing to analyze cellular changes post-treatment.
- Immunofluorescence and experimental verification of M-Ang2-EVs' effects on myelin, axons, and barrier integrity.
Main Results:
- M-Ang2-EVs successfully targeted SCI sites by leveraging Ang2's affinity for LRP-1.
- Treatment with M-Ang2-EVs promoted neuronal and OPCs' transition to nerve repair subtypes.
- M-Ang2-EVs enhanced myelin phagocytosis, axon remyelination, axon elongation, and blood-spinal barrier integrity.
- M-Ang2-EVs demonstrated efficacy in reducing brain inflammation secondary to SCI.
Conclusions:
- M-Ang2-EVs represent a novel therapeutic strategy for spinal cord injury.
- The engineered EVs promote endogenous repair mechanisms and reduce neuroinflammation.
- This approach offers potential for treating both spinal cord and associated brain injuries.
More Related Videos
09:14Experimental Strategies to Bridge Large Tissue Gaps in the Injured Spinal Cord after Acute and Chronic Lesion
Published on: April 5, 2016
08:05Transplantation of Schwann Cells Inside PVDF-TrFE Conduits to Bridge Transected Rat Spinal Cord Stumps to Promote Axon Regeneration Across the Gap
Published on: November 3, 2017